trending Market Intelligence /marketintelligence/en/news-insights/trending/Ef3kY81bsAW10aPJ4hh7kA2 content esgSubNav
In This List

Outlook Therapeutics to implement 1-for-8 reverse stock split

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Outlook Therapeutics to implement 1-for-8 reverse stock split

Outlook Therapeutics Inc.'s board approved a 1-for-8 reverse split of its common stock.

The Cranbury, N.J.-based biopharmaceutical company's common shares will begin trading on a reverse split-adjusted basis from March 18 on the Nasdaq Capital Market.

Outlook's shareholders have already approved the plan.

American Stock Transfer & Trust Co. LLC, which is the company's transfer agent, is acting as the exchange agent for the stock split.